Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
SAQUINAVIR
(1995)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
HIV Infections; Virus Diseases
SAQUINAVIR
×
Maximum Phase:
4
First Approval:
1995
UNII:
L3JE09KZ2F
Molecule Type:
Small molecule
Molecular Formula:
C38H50N6O5
Molecular Weight:
670.86
AlogP:
3.09
PSA:
166.75
HBD:
5.0
HBA:
#RotB:
12.0
Source:
DIRITHROMYCIN
(1995)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Bacterial Infections
DIRITHROMYCIN
×
Maximum Phase:
4
First Approval:
1995
UNII:
1801D76STL
Molecule Type:
Small molecule
Molecular Formula:
C42H78N2O14
Molecular Weight:
835.09
AlogP:
2.2
PSA:
196.33
HBD:
5.0
HBA:
#RotB:
12.0
Source:
BICALUTAMIDE
(1995)
Small molecule
Androgen Receptor antagonist
ORAL
Approved
Carcinoma; Neoplasms
BICALUTAMIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
A0Z3NAU9DP
Molecule Type:
Small molecule
Molecular Formula:
C18H14F4N2O4S
Molecular Weight:
430.38
AlogP:
2.88
PSA:
107.26
HBD:
2.0
HBA:
#RotB:
5.0
Source:
NISOLDIPINE
(1995)
Small molecule
Voltage-gated L-type calcium channel blocker
ORAL
Approved
Cardiovascular Diseases; Hypertension
NISOLDIPINE
×
Maximum Phase:
4
First Approval:
1995
UNII:
4I8HAB65SZ
Molecule Type:
Small molecule
Molecular Formula:
C20H24N2O6
Molecular Weight:
388.42
AlogP:
3.2
PSA:
107.77
HBD:
1.0
HBA:
#RotB:
6.0
Source:
EPOPROSTENOL
(1995)
Small molecule
Unknown
Unknown
Approved
Thrombosis
EPOPROSTENOL
×
Maximum Phase:
4
First Approval:
1995
UNII:
DCR9Z582X0
Molecule Type:
Small molecule
Molecular Formula:
C20H32O5
Molecular Weight:
352.47
AlogP:
3.41
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
10.0
Source:
ALENDRONIC ACID
(1995)
Small molecule
Unknown
Unknown
Approved
Bone Diseases
ALENDRONIC ACID
×
Maximum Phase:
4
First Approval:
1995
UNII:
X1J18R4W8P
Molecule Type:
Small molecule
Molecular Formula:
C4H13NO7P2
Molecular Weight:
249.1
AlogP:
-1.27
PSA:
161.31
HBD:
6.0
HBA:
#RotB:
5.0
Source:
AMIFOSTINE
(1995)
Small molecule
Reactive metabolite scavenging agent
INJECTION
Approved
Head and Neck Neoplasms; Ovarian Neoplasms; Xerostomia
AMIFOSTINE
×
Maximum Phase:
4
First Approval:
1995
UNII:
ILA426L95O
Molecule Type:
Small molecule
Molecular Formula:
C5H15N2O3PS
Molecular Weight:
214.23
AlogP:
-0.25
PSA:
95.58
HBD:
4.0
HBA:
#RotB:
7.0
Source:
IBUTILIDE FUMARATE
(1995)
Small molecule
HERG blocker
INJECTION
Approved
Unknown
IBUTILIDE FUMARATE
×
Maximum Phase:
4
First Approval:
1995
UNII:
9L5X4M5L6I
Molecule Type:
Small molecule
Molecular Formula:
C44H76N4O10S2
Molecular Weight:
885.24
AlogP:
4.16
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
14.0
Source:
EPOPROSTENOL SODIUM
(1995)
Small molecule
Prostanoid IP receptor agonist
INJECTION
Approved
Pulmonary Arterial Hypertension
EPOPROSTENOL SODIUM
×
Maximum Phase:
4
First Approval:
1995
UNII:
4K04IQ1OF4
Molecule Type:
Small molecule
Molecular Formula:
C20H31NaO5
Molecular Weight:
374.45
AlogP:
3.41
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
10.0
Source:
IOXILAN
(1995)
Small molecule
Diagnostic agent
INJECTION
Approved
Unknown
IOXILAN
×
Maximum Phase:
4
First Approval:
1995
UNII:
A4YJ7J11TG
Molecule Type:
Small molecule
Molecular Formula:
C18H24I3N3O8
Molecular Weight:
791.11
AlogP:
-0.99
PSA:
179.66
HBD:
7.0
HBA:
#RotB:
11.0
Source:
ALENDRONATE SODIUM
(1995)
Small molecule
Farnesyl diphosphate synthase inhibitor
ORAL
Approved
Bone Diseases, Metabolic; Osteitis Deformans; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures
ALENDRONATE SODIUM
×
Maximum Phase:
4
First Approval:
1995
UNII:
4988K7X26P
Molecule Type:
Small molecule
Molecular Formula:
C4H12NNaO7P2
Molecular Weight:
271.08
AlogP:
-1.27
PSA:
161.31
HBD:
6.0
HBA:
#RotB:
5.0
Source:
RILUZOLE
(1995)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Amyotrophic Lateral Sclerosis
RILUZOLE
×
Maximum Phase:
4
First Approval:
1995
UNII:
7LJ087RS6F
Molecule Type:
Small molecule
Molecular Formula:
C8H5F3N2OS
Molecular Weight:
234.2
AlogP:
2.78
PSA:
48.14
HBD:
1.0
HBA:
#RotB:
1.0
Source:
IOPROMIDE
(1995)
Small molecule
Diagnostic agent
INJECTION
Approved
Unknown
IOPROMIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
712BAC33MZ
Molecule Type:
Small molecule
Molecular Formula:
C18H24I3N3O8
Molecular Weight:
791.11
AlogP:
-0.41
PSA:
168.66
HBD:
6.0
HBA:
#RotB:
11.0
Source:
NALMEFENE
(1995)
Small molecule
Unknown
Unknown
Approved
Alcoholism
NALMEFENE
×
Maximum Phase:
4
First Approval:
1995
UNII:
TOV02TDP9I
Molecule Type:
Small molecule
Molecular Formula:
C21H25NO3
Molecular Weight:
339.44
AlogP:
2.51
PSA:
52.93
HBD:
2.0
HBA:
#RotB:
2.0
Source:
MYCOPHENOLATE MOFETIL
(1995)
Small molecule
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
ORAL
Approved
Unknown
MYCOPHENOLATE MOFETIL
×
Maximum Phase:
4
First Approval:
1995
UNII:
9242ECW6R0
Molecule Type:
Small molecule
Molecular Formula:
C23H31NO7
Molecular Weight:
433.5
AlogP:
2.52
PSA:
94.53
HBD:
1.0
HBA:
#RotB:
9.0
Source:
LANSOPRAZOLE
(1995)
Small molecule
Potassium-transporting ATPase inhibitor
INTRAVENOUS; ORAL
Approved
Gastroesophageal Reflux; Peptic Ulcer; Stomach Ulcer
LANSOPRAZOLE
×
Maximum Phase:
4
First Approval:
1995
UNII:
0K5C5T2QPG
Molecule Type:
Small molecule
Molecular Formula:
C16H14F3N3O2S
Molecular Weight:
369.37
AlogP:
3.52
PSA:
67.87
HBD:
1.0
HBA:
#RotB:
5.0
Source:
METFORMIN HYDROCHLORIDE
(1995)
Small molecule
Mitochondrial complex I (NADH dehydrogenase) inhibitor
ORAL
Approved
Diabetes Mellitus; Diabetes Mellitus, Type 2
METFORMIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
786Z46389E
Molecule Type:
Small molecule
Molecular Formula:
C4H12ClN5
Molecular Weight:
165.63
AlogP:
-1.03
PSA:
88.99
HBD:
4.0
HBA:
#RotB:
0.0
Source:
SAQUINAVIR MESYLATE
(1995)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
Unknown
SAQUINAVIR MESYLATE
×
Maximum Phase:
4
First Approval:
1995
UNII:
UHB9Z3841A
Molecule Type:
Small molecule
Molecular Formula:
C39H54N6O8S
Molecular Weight:
766.96
AlogP:
3.09
PSA:
166.75
HBD:
5.0
HBA:
#RotB:
12.0
Source:
LATANOPROST
(1996)
Small molecule
Prostanoid FP receptor agonist
OPHTHALMIC
Approved
Glaucoma; Glaucoma, Open-Angle; Hypertension; Ocular Hypertension
LATANOPROST
×
Maximum Phase:
4
First Approval:
1996
UNII:
6Z5B6HVF6O
Molecule Type:
Small molecule
Molecular Formula:
C26H40O5
Molecular Weight:
432.6
AlogP:
4.19
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
13.0
Source:
AMLEXANOX
(1996)
Small molecule
Phosphodiesterase 4 inhibitor
DENTAL; TOPICAL
Approved
Lung Diseases, Obstructive
AMLEXANOX
×
Maximum Phase:
4
First Approval:
1996
UNII:
BRL1C2459K
Molecule Type:
Small molecule
Molecular Formula:
C16H14N2O4
Molecular Weight:
298.3
AlogP:
2.75
PSA:
106.42
HBD:
2.0
HBA:
#RotB:
2.0
Source:
OLOPATADINE HYDROCHLORIDE
(1996)
Small molecule
Histamine H1 receptor antagonist
NASAL; OPHTHALMIC
Approved
Conjunctivitis, Allergic; Pruritus; Rhinitis, Allergic, Seasonal
OLOPATADINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
2XG66W44KF
Molecule Type:
Small molecule
Molecular Formula:
C21H24ClNO3
Molecular Weight:
373.88
AlogP:
3.59
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
5.0
Source:
AMPHETAMINE ASPARTATE
(1996)
Small molecule
Dopamine transporter releasing agent
Unknown
Approved
Unknown
AMPHETAMINE ASPARTATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
H527KAP6L5
Molecule Type:
Small molecule
Molecular Formula:
C13H20N2O4
Molecular Weight:
268.31
AlogP:
1.58
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
2.0
Source:
DOCETAXEL
(1996)
Small molecule
Tubulin inhibitor
INJECTION; INTRAVENOUS
Approved
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms
DOCETAXEL
×
Maximum Phase:
4
First Approval:
1996
UNII:
699121PHCA
Molecule Type:
Small molecule
Molecular Formula:
C43H53NO14
Molecular Weight:
807.89
AlogP:
3.26
PSA:
224.45
HBD:
5.0
HBA:
#RotB:
8.0
Source:
FEXOFENADINE
(1996)
Small molecule
Unknown
Unknown
Approved
Hypersensitivity
FEXOFENADINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
E6582LOH6V
Molecule Type:
Small molecule
Molecular Formula:
C32H39NO4
Molecular Weight:
501.67
AlogP:
5.51
PSA:
81.0
HBD:
3.0
HBA:
#RotB:
10.0
Source:
ALLOPURINOL SODIUM
(1996)
Small molecule
Xanthine dehydrogenase inhibitor
INJECTION
Approved
Unknown
ALLOPURINOL SODIUM
×
Maximum Phase:
4
First Approval:
1996
UNII:
428673RC2Z
Molecule Type:
Small molecule
Molecular Formula:
C5H3N4NaO
Molecular Weight:
158.1
AlogP:
-0.4
PSA:
74.43
HBD:
2.0
HBA:
#RotB:
0.0
Source:
MIDODRINE HYDROCHLORIDE
(1996)
Small molecule
Adrenergic receptor alpha-1 agonist
ORAL
Approved
Unknown
MIDODRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
59JV96YTXV
Molecule Type:
Small molecule
Molecular Formula:
C12H19ClN2O4
Molecular Weight:
290.75
AlogP:
-0.19
PSA:
93.81
HBD:
3.0
HBA:
#RotB:
6.0
Source:
PHENYLBUTANOIC ACID
(1996)
Small molecule
Unknown
Unknown
Approved
Unknown
PHENYLBUTANOIC ACID
×
Maximum Phase:
4
First Approval:
1996
UNII:
7WY7YBI87E
Molecule Type:
Small molecule
Molecular Formula:
C10H12O2
Molecular Weight:
164.2
AlogP:
2.09
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MIRTAZAPINE
(1996)
Small molecule
Adrenergic receptor alpha-2 antagonist
ORAL
Approved
Depressive Disorder; Depressive Disorder, Major; Sleep Initiation and Maintenance Disorders
MIRTAZAPINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
A051Q2099Q
Molecule Type:
Small molecule
Molecular Formula:
C17H19N3
Molecular Weight:
265.36
AlogP:
2.48
PSA:
19.37
HBD:
0.0
HBA:
#RotB:
0.0
Source:
CEFEPIME
(1996)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
CEFEPIME
×
Maximum Phase:
4
First Approval:
1996
UNII:
807PW4VQE3
Molecule Type:
Small molecule
Molecular Formula:
C19H24N6O5S2
Molecular Weight:
480.57
AlogP:
-1.28
PSA:
150.04
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ALBENDAZOLE
(1996)
Small molecule
Tubulin inhibitor
ORAL
Approved
Helminthiasis; Infections; Neurocysticercosis
ALBENDAZOLE
×
Maximum Phase:
4
First Approval:
1996
UNII:
F4216019LN
Molecule Type:
Small molecule
Molecular Formula:
C12H15N3O2S
Molecular Weight:
265.34
AlogP:
3.24
PSA:
67.01
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TOPOTECAN
(1996)
Small molecule
Unknown
Unknown
Approved
Neoplasms
TOPOTECAN
×
Maximum Phase:
4
First Approval:
1996
UNII:
7M7YKX2N15
Molecule Type:
Small molecule
Molecular Formula:
C23H23N3O5
Molecular Weight:
421.45
AlogP:
1.85
PSA:
104.89
HBD:
2.0
HBA:
#RotB:
3.0
Source:
DEXTROAMPHETAMINE SACCHARATE
(1996)
Small molecule
Dopamine transporter releasing agent
Unknown
Approved
Attention Deficit Disorder with Hyperactivity; Narcolepsy
DEXTROAMPHETAMINE SACCHARATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
283TUU52FG
Molecule Type:
Small molecule
Molecular Formula:
C15H23NO8
Molecular Weight:
345.35
AlogP:
1.58
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
2.0
Source:
FOSFOMYCIN TROMETHAMINE
(1996)
Small molecule
UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
ORAL
Approved
Urinary Tract Infections
FOSFOMYCIN TROMETHAMINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
7FXW6U30GY
Molecule Type:
Small molecule
Molecular Formula:
C7H18NO7P
Molecular Weight:
259.19
AlogP:
-0.09
PSA:
70.06
HBD:
2.0
HBA:
#RotB:
1.0
Source:
AZELASTINE HYDROCHLORIDE
(1996)
Small molecule
Histamine H1 receptor antagonist
NASAL; OPHTHALMIC
Approved
Conjunctivitis, Allergic; Nasal Obstruction; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Rhinitis, Vasomotor
AZELASTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
0L591QR10I
Molecule Type:
Small molecule
Molecular Formula:
C22H25Cl2N3O
Molecular Weight:
418.37
AlogP:
4.3
PSA:
38.13
HBD:
0.0
HBA:
#RotB:
3.0
Source:
SPARFLOXACIN
(1996)
Small molecule
Bacterial DNA gyrase inhibitor
ORAL
Approved
Bacterial Infections
SPARFLOXACIN
×
Maximum Phase:
4
First Approval:
1996
UNII:
Q90AGA787L
Molecule Type:
Small molecule
Molecular Formula:
C19H22F2N4O3
Molecular Weight:
392.41
AlogP:
2.08
PSA:
100.59
HBD:
3.0
HBA:
#RotB:
3.0
Source:
VALPROATE SODIUM
(1996)
Small molecule
Succinate semialdehyde dehydrogenase inhibitor
INJECTION
Approved
Epilepsy
VALPROATE SODIUM
×
Maximum Phase:
4
First Approval:
1996
UNII:
5VOM6GYJ0D
Molecule Type:
Small molecule
Molecular Formula:
C8H15NaO2
Molecular Weight:
166.2
AlogP:
2.29
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
1
2
…
43
44
45
46
47
48
49
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA